Prostate Cancer - Results from #120

Accuracy of PET-choline in nodal staging of localized very high-risk prostate cancer. January 3, 2023

Deep learning and radiomics framework for PSMA-RADS classification of prostate cancer on PSMA PET. January 3, 2023

Body composition and mortality in men receiving prostate radiotherapy: A pooled analysis of NRG/RTOG 9406 and NRG/RTOG 0126. January 3, 2023

The presence of lymph node metastases and time to castration resistance predict the therapeutic effect of enzalutamide for castration-resistant prostate cancer. January 3, 2023

Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study. January 2, 2023

MyProstateScore in men considering repeat biopsy: validation of a simple testing approach. January 2, 2023

Prostate-specific Antigen Kinetics During Androgen-deprivation Therapy Predict Response to Enzalutamide in Metastatic Castration-resistant Prostate Cancer. January 2, 2023

Enzalutamide or Abiraterone Acetate With Prednisone in the Treatment of Metastatic Castration-resistant Prostate Cancer in Real-life Clinical Practice: A Long-term Single Institution Experience. January 2, 2023

Integrin Expression in Localized Prostate Cancer: A TCGA and MSKCC Cohort-based Exploratory In Silico Analysis. January 2, 2023

Medium-term oncological outcomes of intermediate-risk prostate cancer treated with HIFU or cryotherapy. A single center 10-year experience. December 30, 2022

A single-operator experience using EchoLaser SoracteLiteTM for focal laser ablation of prostate cancer: One more arrow in the quiver for the conservative management of the disease. December 30, 2022

Clinical impact of ERG and PTEN status in prostate cancer patients underwent radical prostatectomy. December 30, 2022

Nomograms predict survival benefits of radical prostatectomy and chemotherapy for prostate cancer with bone metastases: A SEER-based study. December 30, 2022

18F-PSMA-1007 PET/CT-derived semi-quantitative parameters for risk stratification of newly diagnosed prostate cancer. December 30, 2022

A pilot study of MRI radiomics for high-risk prostate cancer stratification in 1.5 T MR-guided radiotherapy. December 29, 2022

Chronological changes of lower urinary tract symptoms after low-dose-rate brachytherapy for prostate cancer using SpaceOAR® system. December 29, 2022

Conditional gene regulation models demonstrate a pro-proliferative role for growth hormone receptor in prostate cancer. December 29, 2022

Predicting the probability of pT3 or higher pathological stage at radical prostatectomy: COVID19-specific considerations. December 29, 2022

Exome sequencing of affected duos and trios uncovers PRUNE2 as a novel prostate cancer predisposition gene. December 29, 2022

A Phase I Study of Capivasertib in Combination With Abiraterone Acetate in Patients With Metastatic Castration-Resistant Prostate Cancer. December 28, 2022

Page 7 of 1276

email news signup